Nicola Klein to Adverse Drug Reaction Reporting Systems
This is a "connection" page, showing publications Nicola Klein has written about Adverse Drug Reaction Reporting Systems.
Connection Strength
1.442
-
Near Real-Time Surveillance to Assess the Safety of the 9-Valent Human Papillomavirus Vaccine. Pediatrics. 2019 12; 144(6).
Score: 0.166
-
Congenital microcephaly: Case definition & guidelines for data collection, analysis, and presentation of safety data after maternal immunisation. Vaccine. 2017 12 04; 35(48 Pt A):6472-6482.
Score: 0.145
-
Respiratory distress in the neonate: Case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data. Vaccine. 2017 12 04; 35(48 Pt A):6506-6517.
Score: 0.145
-
Identifying birth defects in automated data sources in the Vaccine Safety Datalink. Pharmacoepidemiol Drug Saf. 2017 Apr; 26(4):412-420.
Score: 0.136
-
Case-centered Analysis of Optic Neuritis After Vaccines. Clin Infect Dis. 2016 07 01; 63(1):79-81.
Score: 0.129
-
The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety. Vaccine. 2014 Sep 22; 32(42):5390-8.
Score: 0.115
-
Monitoring the safety of quadrivalent human papillomavirus vaccine: findings from the Vaccine Safety Datalink. Vaccine. 2011 Oct 26; 29(46):8279-84.
Score: 0.094
-
Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network. Pediatrics. 2011 May; 127 Suppl 1:S65-73.
Score: 0.092
-
Active surveillance for adverse events: the experience of the Vaccine Safety Datalink project. Pediatrics. 2011 May; 127 Suppl 1:S54-64.
Score: 0.092
-
Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021. MMWR Morb Mortal Wkly Rep. 2021 Aug 13; 70(32):1094-1099.
Score: 0.047
-
Sensorineural hearing loss (SNHL) as an adverse event following immunization (AEFI): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2020 06 19; 38(30):4717-4731.
Score: 0.043
-
Maternal and Infant Outcomes After Human Papillomavirus Vaccination in the Periconceptional Period or During Pregnancy. Obstet Gynecol. 2017 09; 130(3):599-608.
Score: 0.036
-
Childhood vaccines and Kawasaki disease, Vaccine Safety Datalink, 1996-2006. Vaccine. 2015 Jan 03; 33(2):382-7.
Score: 0.029
-
Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine. Vaccine. 2014 May 23; 32(25):3019-24.
Score: 0.028
-
Clinical assessment of serious adverse events in children receiving 2009 H1N1 vaccination. Pediatr Infect Dis J. 2013 Feb; 32(2):163-8.
Score: 0.026
-
Assessing the safety of influenza vaccination in specific populations: children and the elderly. Expert Rev Vaccines. 2012 Aug; 11(8):973-84.
Score: 0.025
-
Biologically plausible and evidence-based risk intervals in immunization safety research. Vaccine. 2012 Dec 17; 31(1):271-7.
Score: 0.025
-
Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine. J Intern Med. 2012 Feb; 271(2):193-203.
Score: 0.024
-
Overview of the Clinical Consult Case Review of adverse events following immunization: Clinical Immunization Safety Assessment (CISA) network 2004-2009. Vaccine. 2011 Sep 16; 29(40):6920-7.
Score: 0.023
-
The Vaccine Safety Datalink: a model for monitoring immunization safety. Pediatrics. 2011 May; 127 Suppl 1:S45-53.
Score: 0.023